News
CYCN
6.15
-3.61%
-0.23
Deal Dispatch: McCormick, Unilever Merge, Sysco Acquires Jetro Restaurant Depot For $29 Billion, QVC Considers Bankruptcy
Benzinga · 1d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 2d ago
Penny Stock CYCN Surged More Than 300% Yesterday. Why, And Should You Chase the Rally Here?
Barchart · 2d ago
Globalstar, Exxon Mobil, Cyclerion Therapeutics, Eli Lilly And Intel: Why These 5 Stocks Are On Investors' Radars Today
Benzinga · 2d ago
CYCN Stock Alert: Halper Sadeh LLC is Investigating Whether Cyclerion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders
Barchart · 2d ago
Cyclerion Therapeutics to Merge with Korsana Biosciences
TipRanks · 3d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 3d ago
BUZZ-U.S. STOCKS ON THE MOVE-Intel, Tempus AI, Boeing
Reuters · 3d ago
Crude Oil Down Over 1%; ISM Manufacturing PMI Rises In March
Benzinga · 3d ago
Cyclerion Therapeutics Stock Soars 350% On Korsana Merger, $380 Million Financing
Benzinga · 3d ago
Dow Jumps Over 200 Points; Nike Shares Tumble After Q3 Results
Benzinga · 3d ago
ISM Manufacturing unexpectedly rises in March
Seeking Alpha · 3d ago
BUZZ-Cyclerion soars on merger deal with Korsana
Reuters · 3d ago
BUZZ-U.S. STOCKS ON THE MOVE-Cal-Maine, Rivian, Alkermes
Reuters · 3d ago
Cyclerion Soars Over 160% After Announcing Merger With Korsana Biosciences
NASDAQ · 3d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 3d ago
Why is Cyclerion Therapeutics Stock (CYCN) Up Over 160% Today?
TipRanks · 3d ago
BUZZ-U.S. STOCKS ON THE MOVE-Seagate, nCino, Zymeworks
Reuters · 3d ago
BUZZ-Cyclerion rises on merger with Korsana Biosciences, $380 mln funding
Reuters · 3d ago
Cyclerion Therapeutics, Korsana Biosciences enter merger agreement
TipRanks · 3d ago
More
Webull provides a variety of real-time CYCN stock news. You can receive the latest news about Cyclerion Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About CYCN
Cyclerion Therapeutics, Inc. is a biopharmaceutical company dedicated to identifying, developing, and delivering therapies for central nervous system (CNS) diseases. The Company is focused on building a pipeline with therapeutics to treat certain neuropsychiatric diseases. It is focused on an individualized therapy for treatment-resistant depression (TRD) - a condition with significant unmet medical need. Its assets include Olinciguat and Praliciguat. The Company has entered into an exclusive license option agreement for its vascular soluble guanylate cyclase (sGC) stimulator, olinciguat. Praliciguat is an oral, once-daily, systemic sGC stimulator that is licensed to Akeibia Therapeutics, Inc and is being advanced in rare kidney disease.